• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 诱导的 ARVCF 调节剪接景观并支持 p53 的肿瘤抑制功能。

p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53.

机构信息

Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan.

Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, Sapporo, Japan.

出版信息

Oncogene. 2020 Mar;39(10):2202-2211. doi: 10.1038/s41388-019-1133-7. Epub 2019 Dec 11.

DOI:10.1038/s41388-019-1133-7
PMID:31827232
Abstract

p53 is one of the most important tumor suppressor genes, and the exploration of p53-target genes is important for elucidation of its functional mechanisms. In this study, we identified Armadillo Repeat gene deleted in Velo-Cardio-Facial syndrome (ARVCF) as a direct target of p53 through ChIP-sequencing analysis. Activated p53 protein was found to bind to two distinct sites in the ARVCF gene, resulting in induction of ARVCF expression at both the mRNA and protein levels. We revealed that the knockdown of ARVCF inhibited p53-induced apoptosis. Interestingly, ARVCF interacted with hnRNPH2, which is involved in pre-mRNA splicing, and ARVCF knockdown induced dynamic changes in alternative splicing patterns. These results suggest that p53-induced ARVCF indirectly, but not directly, regulates p53 target selectivity through splicing alterations of specific genes. Thus, we demonstrated that the induction of ARVCF expression contributed to the tumor suppressive function of p53. Recently, it has been reported that many tumors have thousands of alternative splicing events that are not detectable in normal samples. ARVCF may play a role in alternative splicing events in cancer and may provide clues to explore novel approaches for cancer diagnosis and therapy.

摘要

p53 是最重要的肿瘤抑制基因之一,探索 p53 的靶基因对于阐明其功能机制非常重要。在这项研究中,我们通过 ChIP-seq 分析鉴定出盔蛋白重复基因缺失的 velo-心-面综合征(ARVCF)是 p53 的直接靶基因。激活的 p53 蛋白被发现与 ARVCF 基因中的两个不同位点结合,导致 ARVCF 在 mRNA 和蛋白水平的表达诱导。我们揭示了 ARVCF 的敲低抑制了 p53 诱导的细胞凋亡。有趣的是,ARVCF 与参与 pre-mRNA 剪接的 hnRNPH2 相互作用,ARVCF 的敲低诱导了特定基因剪接模式的动态变化。这些结果表明,p53 诱导的 ARVCF 通过特定基因剪接的改变间接但不是直接调节 p53 靶标选择性。因此,我们证明了 ARVCF 表达的诱导有助于 p53 的肿瘤抑制功能。最近有报道称,许多肿瘤中有数千种在正常样本中检测不到的可变剪接事件。ARVCF 可能在癌症中的可变剪接事件中发挥作用,并可能为探索癌症诊断和治疗的新方法提供线索。

相似文献

1
p53-induced ARVCF modulates the splicing landscape and supports the tumor suppressive function of p53.p53 诱导的 ARVCF 调节剪接景观并支持 p53 的肿瘤抑制功能。
Oncogene. 2020 Mar;39(10):2202-2211. doi: 10.1038/s41388-019-1133-7. Epub 2019 Dec 11.
2
Nuclear ARVCF protein binds splicing factors and contributes to the regulation of alternative splicing.核 ARVCF 蛋白与剪接因子结合,有助于调节可变剪接。
J Biol Chem. 2014 May 2;289(18):12421-34. doi: 10.1074/jbc.M113.530717. Epub 2014 Mar 18.
3
ARVCF expression is significantly correlated with the malignant phenotype of non-small cell lung cancer.ARVCF表达与非小细胞肺癌的恶性表型显著相关。
Mol Carcinog. 2015 Jun;54 Suppl 1:E185-91. doi: 10.1002/mc.22281. Epub 2015 Feb 14.
4
Association of ARVCF with zonula occludens (ZO)-1 and ZO-2: binding to PDZ-domain proteins and cell-cell adhesion regulate plasma membrane and nuclear localization of ARVCF.ARVCF与紧密连接(ZO)-1和ZO-2的关联:与PDZ结构域蛋白的结合及细胞间黏附调节ARVCF的质膜和核定位。
Mol Biol Cell. 2004 Dec;15(12):5503-15. doi: 10.1091/mbc.e04-04-0350. Epub 2004 Sep 29.
5
Differential expression pattern of protein ARVCF in nephron segments of human and mouse kidney.蛋白质ARVCF在人和小鼠肾脏肾单位各节段中的差异表达模式。
Histochem Cell Biol. 2008 Nov;130(5):943-56. doi: 10.1007/s00418-008-0456-1. Epub 2008 Jul 4.
6
Expression of ARVCF in the human ganglionic eminence during fetal development.ARVCF在胎儿发育期间人神经节隆起中的表达。
Dev Neurosci. 2004 Jan-Feb;26(1):38-44. doi: 10.1159/000080710.
7
Kazrin, and its binding partners ARVCF- and delta-catenin, are required for Xenopus laevis craniofacial development.Kazrin 及其结合伴侣 ARVCF- 和 δ-连环蛋白对于非洲爪蟾颅面部发育是必需的。
Dev Dyn. 2011 Dec;240(12):2601-12. doi: 10.1002/dvdy.22721. Epub 2011 Oct 25.
8
The proteins ARVCF and p0071 in renal cell carcinomas and their potential use in the diagnosis of renal tumours.肾细胞癌中的蛋白质ARVCF和p0071及其在肾肿瘤诊断中的潜在用途。
Histopathology. 2009 Dec;55(6):761-4. doi: 10.1111/j.1365-2559.2009.03444.x.
9
Patterns of Antinuclear Antibodies in a New Variant of Endemic Pemphigus in El Bagre, Colombia, Colocalizing with Antigens against MIZAP, ARVCF, p0071, and Desmoplakins I and II.在哥伦比亚 El Bagre 的一种新型地方性天疱疮的新变体中,抗核抗体的模式与针对 MIZAP、ARVCF、p0071 以及桥粒芯糖蛋白 I 和 II 的抗原发生共定位。
J Appl Lab Med. 2022 Oct 29;7(6):1366-1378. doi: 10.1093/jalm/jfac050.
10
The armadillo repeat region targets ARVCF to cadherin-based cellular junctions.犰狳重复区域将ARVCF靶向基于钙黏蛋白的细胞连接。
J Cell Sci. 2000 Nov;113 ( Pt 22):4121-35. doi: 10.1242/jcs.113.22.4121.

引用本文的文献

1
Long Noncoding RNA RP11-278A23.1, a Potential Modulator of p53 Tumor Suppression, Contributes to Colorectal Cancer Progression.长链非编码RNA RP11-278A23.1是p53肿瘤抑制的潜在调节因子,它促进结直肠癌进展。
Cancers (Basel). 2024 Feb 22;16(5):882. doi: 10.3390/cancers16050882.
2
Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis.长链非编码 RNA LINC01594 通过抑制 CELF6 介导的致癌性 CD44 变体的剪接促进结直肠癌转移。
Cell Death Dis. 2023 Jul 14;14(7):427. doi: 10.1038/s41419-023-05924-8.
3
MYEOV overexpression induced by demethylation of its promoter contributes to pancreatic cancer progression via activation of the folate cycle/c-Myc/mTORC1 pathway.

本文引用的文献

1
Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer.长链非编码RNA NEAT1表达的预后效应取决于癌症中的p53突变状态。
J Oncol. 2019 May 2;2019:4368068. doi: 10.1155/2019/4368068. eCollection 2019.
启动子去甲基化导致 MYEOV 过表达,通过叶酸循环/c-Myc/mTORC1 通路激活促进胰腺癌进展。
BMC Cancer. 2023 Jan 25;23(1):85. doi: 10.1186/s12885-022-10433-6.